glp 1 agonist long term side effects of glp-1 drugs GLP-1 medications, commonly used for type 2 diabetes The expanding role of GLP-1

doi: 10.1016/j.diabres.2013.03.011

Hegeds L, Sherman SI, Tuttle RM, et al

Stomach problems, sometimes severe, have been reported in people who use Wegovy

As a weight management drug, it slows down gastric emptying to prolong the feeling of being full and promotes a feeling of satiety in the brain to reduce cravings

DPP-4 inhibitors have the advantage of decreasing glucagon by augmenting levels of incretin hormones, particularly driving insulin secretion in hyperglycemia to avoid glucagon overproduction

The specificity of the signal (e.g., no increase in non-vestibular ENT diagnoses like hearing loss) further argues against pure detection bias